| Literature DB >> 34563247 |
Javier Gandasegui1,2, Berta Grau-Pujol3,4,5, María Cambra-Pelleja1,2, Valdemiro Escola4, Maria Antonietta Demontis6, Anelsio Cossa4, José Carlos Jamine4, Rafael Balaña-Fouce7, Lisette van Lieshout6, José Muñoz3, María Martínez-Valladares8,9.
Abstract
BACKGROUND: There is an urgent need for an extensive evaluation of benzimidazole efficacy in humans. In veterinary science, benzimidazole resistance has been mainly associated with three single-nucleotide polymorphisms (SNPs) in the isotype-1 β-tubulin gene. In this study, we optimized the stool sample processing methodology and resistance allele frequency assessment in Trichuris trichiura and Necator americanus anthelmintic-related SNPs by pyrosequencing, and standardized it for large-scale benzimidazole efficacy screening use.Entities:
Keywords: Anthelmintic resistance; Benzimidazoles; Pyrosequencing; Soil-transmitted helminths
Mesh:
Substances:
Year: 2021 PMID: 34563247 PMCID: PMC8466976 DOI: 10.1186/s13071-021-04941-w
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Samples flow chart. 1º to 4º indicates the sequence of the workflow
Primers designed by Diawara et al. (2013), and the set designed and optimized by our group (bold italics)
| STH | Sense primer (5′-3′) | Antisense primer (5′-3′) | Pyrosequencing primer |
|---|---|---|---|
| Codon 167 | |||
| GAGTATCCTGACCGAATTATGACA | (Biot)ACGACGTGAACAGTATCAAACAAC | TGACCGAATTATGACAACT | |
| GTGACTGTCTCCAGGTAATTCG | (Biot)CTATAACGTACCTTTGGCGAGGG | GATAGAATCATGTCCTCGT | |
| Codon 198–200 | |||
CGCCTTTTTAGGTTTCAGATACA | (Biot)GTCTCCGTAAGTTGGTGTTGTTAA | GGTAGAGAACACGGACG | |
| TTTCCGACACTGTGGTTGAG | (Biot)GAGTTCGTTACTAGCCAGCTCACC | GAGAATACAGATGAGACCT | |
Fig. 2Comparison of Ct values obtained by real-time PCR for each protocol for sample processing. The dot graph shows the Ct values for each protocol. *Differences between protocols were statistically significant (p < 0.05). Protocol A (unprocessed stool); Protocol B (egg concentration); and Protocol C (egg concentration and flotation with saturated salt solution)
Optimization of pyrosequencing assays using our own primers and the plasmid constructs previously described
| % RT/STa type according to mixes | % of RT/ST observed by pyrosequencing (mean ± SD) | |||
|---|---|---|---|---|
| Codon198 | Codon 200 | Codon 198 | Codon 200 | |
| 0 | 0 (± 0) | 0 (± 0) | 0 (± 0) | 8.8 (± 3.7) |
| 30 | 22.2 (± 1.9) | 21 (± 3.9) | 40.3 (± 6.6) | 38 (± 8.3) |
| 50 | 40.7 (± 2) | 38.7 (± 1.2) | 53.9 (± 2.6) | 52.2 (± 1.1) |
| 70 | 66.1 (± 2.2) | 64.5 (± 1.8) | 66.9 (± 4.1) | 67.5 (± 0.6) |
| 100 | 97.1 (± 2.2) | 97 (± 2.4) | 100 (± 0) | 92.8 (± 2.5) |
aRT/ST: resistant type (RT) and susceptible type (ST) plasmids constructs proportion
Fig. 3Specificity of the pyrosequencing assays for T. trichiura and N. americanus. Specificity assessment performed with the primers for A T. trichiura and B N. americanus is shown. Upper figures show the PCR reaction using the primers for detecting the SNP at codon 167; down figures refer to the primers for the SNPs at codons 198 and 200. The amplicon size is shown in the right position of the gel and it is expressed in base pair (bp). Lane M, 100 bp DNA ladder; lanes Tt, Na, Al, Fh, Fg, Ss, Hc, Tr, Tc, T. trichiura, N. americanus, A. lumbricoides, Fasciola hepatica, Fasciola gigantica, Strongyloides stercoralis, Haemonchus contortus, Trichostrongylus spp. and Teladorsagia circumcincta DNA samples, respectively; lane N, negative control (no DNA template)
Pyrosequencing results of 15 T. trichiura and 15 N. americanus pooled egg samples
| Sample ID | Codon 167 (%) | Codon 198 (%) | Codon 200 (%) | Sample ID | Codon 167 (%) | Codon 198 (%) | Codon 200 (%) |
|---|---|---|---|---|---|---|---|
| T1 | 1.25 | 2 | 0.45 | N1 | 0 | 0 | 0 |
| T2 | 0 | 2.05 | 0 | N2 | 0 | 0 | 1.15 |
| T3 | 5.35 | 2.3 | 0.55 | N3 | 0 | 0 | 0 |
| T4 | 2.1 | 2.35 | 0.65 | N4 | 0 | 0 | 1.5 |
| T5 | 2.75 | 1.9 | 0.4 | N5 | 0 | 0 | 0 |
| T6 | 1.3 | 1.85 | 0 | N6 | 0 | 0 | 1.05 |
| T7 | 0.95 | 2.15 | 0.35 | N7 | 0 | 1.2 | 8.3 |
| T8 | 1.25 | 1.95 | 0.4 | N8 | 0 | 2.05 | 7.45 |
| T9 | 0 | 2.1 | 0 | N9 | 0 | 0 | 0 |
| T10 | 1.95 | 2.5 | 1.65 | N10 | 2.1 | 17 | 0 |
| T11 | 2.6 | 2.1 | 0 | N11 | 0 | 0 | 6.15 |
| T12 | 2.3 | 2.15 | 0.05 | N12 | 0 | 0 | 3.85 |
| T13 | 1.9 | 2.75 | 2.35 | N13 | 0 | 0 | 3.85 |
| T14 | 2.15 | 5.9 | 0 | N14 | 0 | 1.05 | 3.05 |
| T15 | 2.35 | 6.85 | 0 | N15 | 6.85 | 0 | 1.25 |
Results are expressed as frequencies in percentage of resistant genotype